OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 45 filers reported holding OBALON THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,000 | -50.0% | 3,031 | +21.2% | 0.00% | – |
Q1 2019 | $4,000 | -75.0% | 2,500 | -68.8% | 0.00% | – |
Q4 2018 | $16,000 | -88.7% | 8,015 | -84.7% | 0.00% | – |
Q3 2018 | $142,000 | +140.7% | 52,325 | +88.6% | 0.00% | – |
Q2 2018 | $59,000 | -53.2% | 27,751 | -24.2% | 0.00% | – |
Q1 2018 | $126,000 | -39.4% | 36,594 | +16.4% | 0.00% | – |
Q4 2017 | $208,000 | +27.6% | 31,442 | +84.6% | 0.00% | – |
Q3 2017 | $163,000 | -2.4% | 17,036 | +1.0% | 0.00% | – |
Q2 2017 | $167,000 | +31.5% | 16,859 | +42.2% | 0.00% | – |
Q1 2017 | $127,000 | +130.9% | 11,856 | +90.8% | 0.00% | – |
Q4 2016 | $55,000 | – | 6,215 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|